Inocucor 是一家为中耕作物和高价值农产品生产生物作物投入物的农业科技公司，其制造顾问委员会新增了两位农业生物科学领导者 Carole Cobb 和 Gregg Bogosian 博士。
Under the direction of Board Chair Jeff Lievense, Ph.D., one of the world’s leading experts on fermentation process engineering, the independent advisory team will assist in the design of Inocucor’s new production facility at its 30,000-square-foot U.S. headquarters and commercialization office in Centennial, Colo. It also will offer expertise as Inocucor scales up its process development and pilot manufacturing capabilities at the company’s Technical Center of Excellence, a 20,000-square-foot facility in Montreal.
Cobb is COO of GreenLight BioSciences and has over 30 years’ experience in industrial biotechnology, worldwide manufacturing, technology acquisition, global supply chain and start-ups. She has overseen numerous fermentation-based manufacturing plants in the U.S., Europe, China and South America, as well as three major warehouse/distribution centers. She holds an MBA in Finance from the University of Rochester and a B.S. in Chemical Engineering, Biochemistry, and Cell and Molecular Biology from the State University of New York at Buffalo.
Bogosian is a consultant with more than 35 years’ experience in biotechnology, specializing in the use of fermentation to produce microbial products. He is experienced in cGMP-compliant manufacturing of biologicals. Bogosian holds a Ph.D. in Biochemistry from Purdue University and has completed postdoctoral studies in Microbiology at the University of North Carolina at Chapel Hill. He earned a B.A. in Zoology at Miami University.
Inocucor 使用获得专利的发酵工艺将多种细菌和酵母菌组合成强大的土壤和植物优化剂，对人类和环境都是安全的。这些产品自然地提高了作物产量，缩短了生长期，并为农民和温室种植者创造了更健康、更有弹性的土壤。
Inocucor 最近完成了其 B 轮融资的 $3880 万加元（$29 百万美元）的第一轮融资，主要投资者 TPG Alternative and Renewable Technologies（旧金山）和 Cycle Capital Management（魁北克）、Desjardins Innovatech（魁北克）的参与和闭环资本（美国）。